PF-03715455

DRUG4 trials

Sponsors

Pfizer

Conditions

AsthmaChronic Obstructive Pulmonary Disease (COPD)Healthy VolunteersPulmonary Disease, Chronic Obstructive

Phase 1

Multiple Dose Healthy Volunteer Study of PF-03715455.

CompletedNCT01186757

PfizerHealthy Volunteers

Start: 2010-08-31End: 2011-01-31Updated: 2011-01-12

Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers

CompletedNCT01314885

PfizerChronic Obstructive Pulmonary Disease (COPD)

Start: 2011-01-31End: 2011-12-31Updated: 2012-02-02

Phase 2

An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma

TerminatedNCT02219048

Start: 2014-11-30End: 2015-05-31Updated: 2019-06-12

An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease

TerminatedNCT02366637

PfizerPulmonary Disease, Chronic Obstructive

Start: 2015-01-31End: 2015-05-31Updated: 2016-07-06